Skip To Main Content
Mingduan Chen on Muck Rack

Mingduan Chen

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mingduan

Contact Mingduan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effectiveness comparison of pembrolizumab versus other immune checkpoint inhibitors in neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma

|
By Shuhan Xie, Zhinuan Hong, Mingqiang Kang, Mingduan Chen
| Frontiers
Abstract Background and purpose: Neoadjuvant chemoimmunotherapy (nICT) has emerged as a promising strategy for esophageal squamous cell carcinoma (ESCC). However, the efficacy and safety comparison of imported and domestic immune drugs remain unclear. This study aimed to compare short- and long-term efficacy between domestic and imported immunotherapeutic agents. Method: A total of 128 ESCC patients were retrospectively analyzed.
Open in Who Shared Issue with article?
See all 1 articles